Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening Products

U.N. Human Rights Council Adopts 'Landmark' Maternal Mortality Resolution
The U.N. Human Rights Council adopted a "landmark resolution" acknowledging that "preventable maternal mortality and morbidity" is a human rights issue and that national and international efforts to protect women worldwide should be scaled up, the Hudson Valley Press Online reports. More than 70 U.N. member states cosponsored the resolution, led by Colombia and New Zealand (Hudson Valley Press Online, 6/18). Pakistan was one of the member states that signed on to the resolution, the International News reports (International News, 6/19).
generic viagra online
CareFirst BCBS Covers ENO Measurement For Diagnosis, Asthma Treatment
Apieron, Inc. said that CareFirst BlueCross BlueShield has adopted a positive coverage policy for the measurement of exhaled nitric oxide (eNO). The Medical Directors of CareFirst determined that the published, peer-reviewed evidence is sufficient to support benefit coverage for the treatment of asthma. The policy, effective July 20, 2009, states the measurement of exhaled nitric oxide is considered medically necessary in the management of asthma patients. CareFirst is the largest health care insurer in the Mid-Atlantic region, serving nearly 3.4 million members in Maryland, District of Columbia and portions of Virginia.
News of the day
News From The American Chemical Society, June 24, 2009
Potential new drugs: 970 million and still counting
Medical Devices

Biological Warfare In Bacteria Offers Hope For New Antibiotics

Scientists are to study a group of proteins that are highly effective at killing bacteria and which could hold the key to developing new types of antibiotics. Researchers from the Universities of York and Leeds have been awarded ÷£3.3m from the Biotechnology and Biological Sciences Research Council (BBSRC) to find out how a family of proteins known as colicins force their way into bacterial cells before destroying them. The team, led by Professor Colin Kleanthous, from the University of York"s Department of Biology, will develop earlier research that suggests colicins use decoys to mimic key parts of the cells" own protein machinery to evade their defences. Professor Kleanthous said: "Colicins are the weapon used in the biological warfare that takes place between competing bacteria. Understanding how this group of proteins work could help scientists develop new drug delivery methods to target the bacteria that cause diseases in people." "It"s as though the colicins are carrying the equivalent of hand grenades which they can deploy without harming themselves," said Professor Sheena Radford of the University of Leeds" Faculty of Biological Sciences. The five year programme of research aims to discover how colicins specifically penetrate Gram-negative bacteria which are protected by two membrane barriers. It will involve collaboration between six groups of scientists from the Departments of Biology and Chemistry at the University of York and the Astbury Centre for Structural and Molecular Biology, Faculty of Biological Sciences, at the University of Leeds. York University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009